Amir Nashat - Net Worth and Insider Trading

Over the past 18 months, Amir Nashat made no insider transaction in aTyr Pharma Inc (LIFE). Other recent insider transactions involving aTyr Pharma Inc (LIFE) include a net purchase of 55,000 shares made by Sanjay Shukla , a net sale of 3,156 shares made by Jill Marie Broadfoot , and a net purchase of 200,000 shares made by Paul Schimmel .

In summary, during the past 3 months, insiders sold 1,590 shares of aTyr Pharma Inc (LIFE) in total and bought 0 shares, with a net sale of 1,590 shares. During the past 18 months, 3,156 shares of aTyr Pharma Inc (LIFE) were sold and 255,000 shares were bought by its insiders, resulting in a net purchase of 251,844 shares.

aTyr Pharma Inc (LIFE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Amir Nashat made no insider transaction in Fate Therapeutics Inc (FATE). Other recent insider transactions involving Fate Therapeutics Inc (FATE) include a net sale of 26,108 shares made by Dulac Edward J Iii , a net purchase of 44,630 shares made by Redmile Group, Llc , and a net sale of 46,790 shares made by Cindy Tahl .

In summary, during the past 3 months, insiders sold 1,849 shares of Fate Therapeutics Inc (FATE) in total and bought 0 shares, with a net sale of 1,849 shares. During the past 18 months, 479,444 shares of Fate Therapeutics Inc (FATE) were sold and 471,648 shares were bought by its insiders, resulting in a net sale of 7,796 shares.

Fate Therapeutics Inc (FATE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Amir Nashat made no insider transaction in Cartesian Therapeutics Inc (RNAC). Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net purchase of 1,223,316 shares made by Timothy A Springer , a net sale of 48,524 shares made by Carsten Brunn , and a net sale of 12,349 shares made by Peter G Traber .

In summary, during the past 3 months, insiders sold 0 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 40,777 shares, with a net purchase of 40,777 shares. During the past 18 months, 2,681 shares of Cartesian Therapeutics Inc (RNAC) were sold and 40,777 shares were bought by its insiders, resulting in a net purchase of 38,096 shares.

Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Amir Nashat made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net sale of 689 shares made by Eric R Olson .

In summary, during the past 3 months, insiders sold 10,601 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 0 shares, with a net sale of 10,601 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 904,977 shares were bought by its insiders, resulting in a net purchase of 873,765 shares.

Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Amir Nashat made no insider transaction in Metacrine Inc (MTCR). Other recent insider transactions involving Metacrine Inc (MTCR) include a net purchase of 1,248,404 shares made by Braden Michael Leonard , a net sale of 380,605 shares made by Preston Klassen , and a net sale of 107,054 shares made by Michael York .

In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 487,659 shares of Metacrine Inc (MTCR) were sold and 1,248,404 shares were bought by its insiders, resulting in a net purchase of 760,745 shares.

Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Amir Nashat made no insider transaction in Morphic Holding Inc (MORF). Other recent insider transactions involving Morphic Holding Inc (MORF) include a net sale of 58,357 shares made by Praveen P. Tipirneni , a net sale of 56,337 shares made by Farrell Robert E Jr , and a net sale of 127,711 shares made by Marc Schegerin .

In summary, during the past 3 months, insiders sold 0 shares of Morphic Holding Inc (MORF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 317,833 shares of Morphic Holding Inc (MORF) were sold and 1,054,776 shares were bought by its insiders, resulting in a net purchase of 736,943 shares.

Morphic Holding Inc (MORF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Amir Nashat made no insider transaction in Scholar Rock Holding Corp (SRRK). Other recent insider transactions involving Scholar Rock Holding Corp (SRRK) include a net sale of 83,758 shares made by Edward H Myles , a net purchase of 2,279,168 shares made by Invus Public Equities, L.p. , and a net sale of 31,121 shares made by Mo Qatanani .

In summary, during the past 3 months, insiders sold 11,007 shares of Scholar Rock Holding Corp (SRRK) in total and bought 0 shares, with a net sale of 11,007 shares. During the past 18 months, 128,112 shares of Scholar Rock Holding Corp (SRRK) were sold and 6,659,824 shares were bought by its insiders, resulting in a net purchase of 6,531,712 shares.

Scholar Rock Holding Corp (SRRK)'s detailed insider trading history can be found in Insider Trading Tracker table.